Variant report
Variant | esv1819763 |
---|---|
Chromosome Location | chr20:1386940-1390683 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:6)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:6 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr20:1384990..1387871-chr20:1389849..1391425,2 | K562 | blood: | |
2 | chr20:1374791..1377395-chr20:1388884..1390483,2 | K562 | blood: | |
3 | chr20:1384990..1387871-chr20:1389849..1391425,2 | K562 | blood: | |
4 | chr20:1387186..1389098-chr20:1391471..1393677,2 | MCF-7 | breast: | |
5 | chr20:1388186..1390453-chr20:1399929..1402694,2 | K562 | blood: | |
6 | chr20:1389651..1392477-chr20:1392965..1396440,4 | K562 | blood: |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-FKBP1A-3 | chr20:1389013-1389091 | NONHSAT078110 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs1998007 | chr20:1386940-1386941 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs35162778 | chr20:1386996-1386997 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs6079009 | chr20:1387039-1387040 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs6109819 | chr20:1387057-1387058 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs6079010 | chr20:1387092-1387093 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs573226675 | chr20:1387111-1387112 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs545329354 | chr20:1387113-1387114 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs565754997 | chr20:1387162-1387163 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs534589912 | chr20:1387199-1387200 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs190128994 | chr20:1387208-1387209 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs141255269 | chr20:1387227-1387228 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs535160466 | chr20:1387257-1387258 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs182080081 | chr20:1387263-1387264 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs34712335 | chr20:1387266-1387267 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs529745065 | chr20:1387267-1387268 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs546624623 | chr20:1387334-1387335 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs6079012 | chr20:1387340-1387341 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
18 | rs538206272 | chr20:1387356-1387357 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs6079013 | chr20:1387366-1387367 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs58475841 | chr20:1387369-1387370 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs186711567 | chr20:1387393-1387394 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs371680687 | chr20:1387422-1387423 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs77471927 | chr20:1387461-1387462 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs8124855 | chr20:1387475-1387476 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs192386480 | chr20:1387495-1387496 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs534324007 | chr20:1387497-1387498 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs13037197 | chr20:1387509-1387510 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs6079015 | chr20:1387621-1387622 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs1474880 | chr20:1387658-1387659 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
30 | rs6131468 | chr20:1387687-1387688 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
31 | rs545390404 | chr20:1387691-1387692 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs185476282 | chr20:1387705-1387706 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs575596135 | chr20:1387710-1387711 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs150761559 | chr20:1387731-1387732 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs6074593 | chr20:1387771-1387772 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs139095232 | chr20:1387824-1387825 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs144027390 | chr20:1387886-1387887 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs559782453 | chr20:1387893-1387894 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs6514382 | chr20:1387918-1387919 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
40 | rs551735226 | chr20:1387939-1387940 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs189198852 | chr20:1387948-1387949 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs6514383 | chr20:1387950-1387951 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs371812234 | chr20:1387988-1387989 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs145944823 | chr20:1388063-1388064 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs6109825 | chr20:1388068-1388069 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs7270038 | chr20:1388096-1388097 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs6105079 | chr20:1388170-1388171 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs139805194 | chr20:1388185-1388186 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs114191219 | chr20:1388200-1388201 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs4814229 | chr20:1388219-1388220 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
Disease | PMID | Source |
---|---|---|
Hodgkin''s lymphoma | 18641027 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intellectual disability | 22045946 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Colorectal cancer | 19455253 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Breast cancer | 17603634 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Autism | 18414403 | CNVD |
Neurocytoma | 17123091 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 16397240 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Wilms tumour | 21544195 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 16272173 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 19627613 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Central neurocytomas | 17123091 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Gastric cancer | 17908304 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Oral cancer | 21386901 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 18438408 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Colorectal cancer | 21645411 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 17363583 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr20:1380600-1388400 | Weak transcription | Skeletal Muscle Female | skeletal muscle |
2 | chr20:1382400-1388400 | Weak transcription | Placenta | Placenta |
3 | chr20:1383200-1388000 | Weak transcription | Foreskin Fibroblast Primary Cells skin01 | Skin |
4 | chr20:1383800-1396000 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
5 | chr20:1384400-1395600 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
6 | chr20:1384400-1396000 | Weak transcription | HMEC | breast |
7 | chr20:1385600-1387800 | Enhancers | Fetal Intestine Large | intestine |
8 | chr20:1385800-1387600 | Enhancers | Fetal Intestine Small | intestine |
9 | chr20:1388400-1389000 | Strong transcription | Skeletal Muscle Female | skeletal muscle |
10 | chr20:1388400-1389200 | Enhancers | Placenta | Placenta |
11 | chr20:1389000-1396800 | Weak transcription | Skeletal Muscle Female | skeletal muscle |
12 | chr20:1389200-1396400 | Weak transcription | Placenta | Placenta |
13 | chr20:1390200-1390600 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
14 | chr20:1390600-1396600 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |